Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

British Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 893-897

  Ablashi, D ^a   Chatlynne, L ^a   Cooper, H ^a   Thomas, D ^a   Yadav, M ^b   Norhanom, A W ^b   Chandana, A K ^b   Churdboonchart, V ^c   Kulpradist, S A R ^c   Patnaik, M ^d   Liegmann, K ^d   Masood, R ^e   Reitz, M ^f   Cleghorn, F ^f   Manns, A ^g   Levine, P H ^h   Rabkin, C ^g   Biggar, R ^g   Jensen, F ⁱ   Gill, P ^e   Jack, N ^j   Edwards, J ^j   Whitman, J ^a   Boshoff, C ^k   more..

^a Advanced Biotechnologies Inc   (United States)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Specialty Laboratories   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

ⁱ Orchestra Therapeutics Inc   (United States)

^j Med Res Found of Trinidad and T   (United States)

^k INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS REACTION; EPSTEIN BARR VIRUS; FEMALE; GHANA; HERPES; HONG KONG; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDIA; JAMAICA; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MOUTH CARCINOMA; NASOPHARYNX TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; SOUTHEAST ASIA; SRI LANKA; THAILAND; TRINIDAD AND TOBAGO; UGANDA; UNITED STATES; ZAMBIA;

ADOLESCENT; ADULT; AFRICA; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CARIBBEAN REGION; CHILD; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 0032718747     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690782     Document Type: Article

References (30)

1. Bestetti G, Renon G, Mauclere P, Ruffic A, Mbopi Keou FX, Emo D, Parravicini C, Corbellino M, de Thé G and Gessain A (1998) High seroprevalence of human herpesvirus 8 in pregnant women and prostitutes from Cameroon. AIDS 12: 541-543
2. Bhoopat L, Thampraser K, Chalwan B, Attasiri C, Vithayasal P and Chaimongkoi B (1994) Histopathologic spectrum of AIDS associated lesions in Maharaj Nakon Chaing Mai Hospital. Asian Pac J Immunol 12: 95-104
3. Boshoff C and Weiss R (1998) Kaposi's sarcoma-associated herpesvirus. Adv Cancer Biol Res 75: 57-86
4. Bourboulia D, Whitby D, Boshoff C, Newton R, Beral V, Carrara H, Lane A and Sitas F (1998) Serological evidence for vertical transmission of KSHV/HHV-8 in healthy South African children. J Am Med Assoc 280: 31-32
5. Chang Y and Moore PS (1996) Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5: 215-222
6. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS (1994) Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 265: 1865-1869
7. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, Gill PS, Whitman JE and Ablashi DV (1998) Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92: 53-58
8. Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Strauss SF and Yarchoan R (1997) Detection of serum antibodies to Kaposi's sarcoma-associated herpesvirus specific peptides. J Infect Dis 175: 1971-1979
9. Ganem D (1996) Human herpesvirus 8 and the biology of Kaposi's sarcoma. Semin Virol 7: 325-332
10. Gao SJ, Kingsley L, Li M, Zheng W, Parravinci C, Zeigler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y and Moore P (1996a) KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat Med 2: 925-928
11. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y and Moore PS (1996b) Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335: 233-241
12. Gessain A, Mauclère P, Van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono J-L, Martin PMV and de Thé G (1999) Human herpesvirus-8 primary infection occurs during childhood in Cameroon, Central Africa. Intl J Cancer 81: 189-192
13. Gill PS (1998) Personal Communication. University of Southern California, Los Angeles, CA, USA
14. IARC Monographs Volume 70 (1997) On Epstein-Barr Virus and Human Herpesvirus-8. Published by World Health Organization Intl Agency for Res on Cancer, 1997
15. Jensen F (1998) Personal Communication. Immune Response Corporation, Carlsbad, CA, USA
16. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J and Ganem D (1996) The seroepidemiology of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2: 918-924
17. Lin SF, Sun R, Heston L, Granville L, Shedd D, Haglaund K, Rigsby M and Miller G (1997) Identification, expression, and immunogenieity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 71: 3069-3076
18. Luppi MD, Whitby D, Barozzi P, Boshoff C, Weiss RW, Cucci F and Torelli G (1998) Age and sex-specific seroprevalence of human herpesvirus 8 in Jamaica response. J Natl Cancer Inst 90: 1103-1104
19. Manns A, Strickler HD, Hanchard B, Manassaram DM, Waters D and Ablashi DV (1998) Age- and sex-specific seroprevalence of human herpesvirus-8 in Jamaica. J Natl Cancer Inst 90: 1102-1103
20. Martin JN, Ganem DE, Osmond DH, Page-Schafer KA, Macrae D and Kedes DH (1998) Sexual transmission and the natural history of human herpesvirus-8 infection. N Engl J Medicine 338: 948-954
21. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chan Y and Moore P (1996) Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-I infection. N Engl J Med 334: 1292-1297
22. Oskenhendler E, Cazals-Hatem D, Schulz TF, Baratean V, Grollet L, Sheldon J, Clauvel JP, Sigaux F and Agbalika F (1998) Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus-8 in a patient with human immunodeficiency virus infection. N Engl J Med 338: 1585-1590
23. Raab MS, Albrecht JC, Birkman A, Yaguboglu S, Lang D, Fleekenstein B and Neipel F (1998) The immunogenic glycoprotein gp35-37 of human herpesvirus-8 is encoded by open reading frame K8.I. J Virol 72: 6725-6731
24. Schulz TF (1998) Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79: 1573-1591
25. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, deRuiter A, Hatzakism A, Tedder RS, Weller IVD, Weiss RA and Moore PS (1996) Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348: 1133-1138
26. Sukpanichant S, Sonakul D, Plankijagum A, Wanachiwanawin W, Veerakul G, Mahasandana C, Tanphalchitr VS and Suvatte V (1998) Malignant lymphoma in Thailand. Cancer 83: 1197-1204
27. Verbeek W, Frankel M, Miles S, Said J and Koeffler HP (1998) Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up. Microbiol Infect Dis 109: 778-783
28. Wabinga HR, Pakin DM, Wabwire-Mangen F and Mugerwa JW (1993) Cancer in Kampala, Uganda in 1989-1991: changes in incidence in the era of AIDS. Intl J Cancer 54: 23-36
29. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA and Torelli G (1998) HHV-8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90: 395-397
30. Ziegler JL (1993) Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 342: 1348-1351